ICU Medical, Inc. (ICUI) Stock Analysis

    $ICUI · Healthcare · Medical - Instruments & Supplies

    ICU Medical (ICUI), a Medical - Instruments & Supplies company, has a market capitalization of about $4.35B and trades at 82.9x trailing earnings.

    Price

    $174.04

    Market cap

    $4.35B

    P/E ratio

    82.9x

    Dividend yield

    —

    About ICU Medical, Inc.

    ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common fo

    How StockWorthy values ICUI

    StockWorthy forecasts ICU Medical, Inc.'s revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from ICUI's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.

    Related stocks

    See ICUI's Fair Value

    Create a free account to view ICU Medical, Inc.'s base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.